Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above

NCT07152639 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1784

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: 5μg/ml EEC
BIOLOGICAL: 5 unit（U） EC
BIOLOGICAL: 5 IU TB-PPD
DIAGNOSTIC_TEST: IGRA

Sponsor

Chengdu CoenBiotech Co., Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]